OPG inhibits the differentiation and development of osteoclast by interfering with the binding of RANKL and its receptor, RANK, and a lack of OPG induces severe osteopenia and osteoclastogenesis (Xu and Jiang 2010). Here, TNFRSF11A is linked to Osteopenia.